Albiotic Ενδομαστικό διάλυμα
Albiotic Ενδομαστικό διάλυμα
Authorised
- Lincomycin
- Neomycin
Product identification
Medicine name:
Albiotic Ενδομαστικό διάλυμα
Active substance:
- Lincomycin
- Neomycin
Target species:
-
Cattle (lactating cow)
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Lincomycin330.00/milligram(s)10.00millilitre(s)
-
Neomycin100.00/milligram(s)10.00millilitre(s)
Pharmaceutical form:
-
Intramammary solution
Withdrawal period by route of administration:
-
Intramammary use
- Cattle (lactating cow)
-
Milk84hour
-
Meat3day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51RF03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Cyprus
Available in:
-
Cyprus
Package description:
- Available only in Greek
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- HuVepharma
Marketing authorisation date:
Manufacturing sites for batch release:
- Norbrook Laboratories Limited
Responsible authority:
- Veterinary Services, Ministry Of Agriculture, Natural Resources And Environment
Authorisation number:
- 7855
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 2/03/2022
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 27/06/2022
How useful was this page?:
